PubRank
Search
About
Felipe C Geyer
Author PubWeight™ 39.92
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells.
Cell Stem Cell
2010
4.66
2
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
Breast Cancer Res Treat
2009
1.93
3
Whole genome sequencing of matched primary and metastatic acral melanomas.
Genome Res
2011
1.90
4
Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia.
N Engl J Med
2010
1.90
5
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Am J Surg Pathol
2013
1.83
6
Breast cancer precursors revisited: molecular features and progression pathways.
Histopathology
2010
1.72
7
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors.
Sci Transl Med
2010
1.64
8
Histological types of breast cancer: how special are they?
Mol Oncol
2010
1.58
9
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
Clin Cancer Res
2009
1.49
10
Non-existence of caveolin-1 gene mutations in human breast cancer.
Breast Cancer Res Treat
2011
1.47
11
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer.
Eur J Cancer
2010
1.40
12
Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas.
Clin Cancer Res
2011
1.27
13
Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
Mod Pathol
2009
1.25
14
Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type.
Cancer Cell
2011
1.25
15
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
J Pathol
2010
1.25
16
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.
J Pathol
2010
1.23
17
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
J Pathol
2011
1.14
18
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
J Pathol
2009
1.08
19
Functional characterization of the 19q12 amplicon in grade III breast cancers.
Breast Cancer Res
2012
1.06
20
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
Genes Chromosomes Cancer
2009
1.02
21
A mouse model of melanoma driven by oncogenic KRAS.
Cancer Res
2010
0.96
22
Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.
J Pathol
2010
0.95
23
Genomic profiling of histological special types of breast cancer.
Breast Cancer Res Treat
2013
0.93
24
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study.
Mod Pathol
2010
0.92
25
β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
Mod Pathol
2010
0.89
26
14-3-3σ stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion.
Proc Natl Acad Sci U S A
2013
0.89
27
DNA amplifications in breast cancer: genotypic-phenotypic correlations.
Future Oncol
2010
0.89
28
Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome.
J Clin Pathol
2010
0.85
29
Absence of microsatellite instability in mucinous carcinomas of the breast.
Int J Clin Exp Pathol
2010
0.81
30
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study.
Breast Cancer Res Treat
2010
0.81